HYCOR appoints new Chief Financial Officer
HYCOR Biomedical, Inc., a leading manufacturer and marketer of in vitro diagnostic products for the global allergy, autoimmune and urinalysis markets, today announced that Ed Cordell (pictured) has joined the company as Chief Financial Officer.
“Ed’s three decade career brings a set of invaluable skills that we need as we embark on our next phase of growth,” said Dick Aderman, CEO, HYCOR. “His tested financial and strategy expertise will help ensure HYCOR remains on a strong path to meet our customer and investors expectations. We welcome Ed and are thrilled to have such a high caliber executive join our team.”
Cordell is a seasoned financial executive with more than 30 years of experience and a proven record of success. He joins HYCOR from Given Imaging, Inc., a world leader in GI medical devices and pioneer of capsule endoscopy, where he was Chief Financial Officer with responsibility for the North and South American regions. Cordell brings extensive expertise in operational, accounting and financial challenges of building high-growth and high-tech businesses with a majority of focus on medical device companies.
Cordell has also held senior financial executive positions with Gravograph, the world’s leading maker and seller of machines, accessories and materials used in the engraving industry, Novoste Corporation, who was the first company to develop and market a radiation therapy system to treat restenosis and CryoLife, a producer of implantable living human tissues and surgical adhesives. Cordell received his Bachelor of Science degree from the University of Tennessee.
“I’m very excited to join HYCOR during this crucial time as the company moves to expand the business,” said Cordell. “I look forward to joining a superb leadership team and working with them to support the continued growth.”
- Special Reports
- By Location
- By Subject
Latest Special Report
- How to set up a hedge fund